Alzheon is a series c plus startup based in United States. 2 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Alzheon, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drugs for patients suffering from Alzheimer's disease and other neurodegenerative disorders.
Stage
series-c-plus
Investors
2
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky